AGMAX

Eca Healthcare Inc.

Application Filed: 2013-09-07
Trademark Application Details
Trademark Logo AGMAX
602
Dead/Abandoned
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Research OneLook Acronym Finder
Serial Number86058412
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Law Office AssignedL20
Employee NameCOLEMAN, CIMMERIAN

Timeline

2008-05-08Date of First Use
2013-09-07Application Filed
2014-06-19Abandon
2014-07-16Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
2014-07-16Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: ECA HEALTHCARE INC.
AddressRm.1017 North Bldg., No. 1839 Qixin Rd., Shanghai CN 201101
Legal Entity TypeLimited Liability Company
Legal Entity State CN

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

ECA HEALTHCARE INC.
P.O.BOX 100045-28
BEIJING
100045
CHINA

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Albumin dietary supplements; Alginate dietary supplements; Alkalinity buffer supplements for live coral for use in aquariums; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Antioxidant enriched coffee; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Calcium-based nutrient supplements for live coral for use in aquariums; Casein dietary supplements; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Enzyme food supplements; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Food supplements; Glucose dietary supplements; Ground flaxseed fiber for use as a dietary supplement; Health food supplements; Herbal supplements; Herbal supplements for sleeping problems; Homeopathic supplements; Human allograft bone and tissue; Human allograft tissue; Human growth hormone; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Lecithin for use as a dietary supplement; Linseed dietary supplements; Linseed oil dietary supplements; Liquid herbal supplements; Liquid nutritional supplement; Liquid protein supplements; Medical adhesive tape; Medical adhesives for binding internal tissue; Medical adhesives for binding wounds; Medical and surgical dressings; Medical and surgical plasters; Medical cleansers for skin and wounds; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical dressings; Medical lubricant, namely, vaginal lubricants; Medical plasters; Medical preparations for slimming purposes; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicinal alcohol; Medicinal creams for skin care; Medicinal drinks; Medicinal hair growth preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal oils; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal radix glycyrrhizae; Medicinal roots; Medicinal tea; Medicines for dental purposes; Medicines for the treatment of gastrointestinal diseases; Mineral nutritional supplements; Non-medicated additives for animal feed for use as nutritional supplements; Nopal cactus juice for use as a nutritional supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritional supplements, namely, probiotic compositions; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Nutritive substances for microorganisms for medical purposes; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Veterinary preparations, namely, antioxidants

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2013-09-111 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2013-09-162 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2013-12-183 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2013-12-184 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2013-12-185 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2013-12-186 GNRN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2014-07-167 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2014-07-168 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed